HealthQuest Capital
HealthQuest Capital is a growth equity, private equity firm investing in commercial-stage companies across the healthcare industry
Business Model:
Revenue: $5.9M
Employees: 11-50
Rankings
Industries / Tags:
Detailed HealthQuest Capital Information
Geographic Data
Address: 3000 Sand Hill Rd
City: Menlo Park
State: CA
Zip: 94025
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$1B
Social
Linkedin
Crunchbase
Metrics
4,315,951Website Global Rank
2,404Website Monthly Traffic
Twitter Followers
Description
HealthQuest Capital is a growth equity, private equity firm investing in commercial-stage companies across the healthcare industry, including medical devices, biopharma, healthcare services, and healthcare IT
Contact Phone:
+16506818420
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 11/2015 | First Aid Shot Therapy | Series C | 24M |
| 6/2021 | Thirty Madison | Series C | 0 |
| 2/2016 | Vestagen Technical Textiles | Venture Round | 7M |
| 7/2016 | Avizia | Series A | 11M |
| 1/2019 | Harmony Home Health | Private Equity Round | - |
| 3/2018 | BioIQ | Venture Round | 26.5M |
| 1/2019 | Magnolia Medical Technologies | Series C | 0 |
| 10/2017 | Vestagen Technical Textiles | Venture Round | 0 |
| 9/2015 | Vestagen Technical Textiles | Convertible Note | 3.3M |
| 8/2014 | Castle Biosciences | Venture Round | 11.8M |
| 4/2019 | Ajax Health | Series C | 85M |
| 1/2015 | Lineagen | Series C | 0 |
| 6/2022 | Nomad Health | Venture Round | 0 |
| 11/2021 | Lunit | Venture Round | 0 |
| 1/2016 | Biotheranostics | Venture Round | 32M |
| 2/2022 | Magnolia Medical Technologies | Venture Round | 0 |
| 5/2018 | Avedro | Series F | 0 |
| 12/2019 | RareCyte | Equity | 22M |
| 5/2018 | CleanSlate | Equity | 25M |
| 1/2023 | Clearsense | Series D | 50M |
| 10/2015 | inMediata | Venture Round | 4M |
| 6/2019 | Ajax Health | Series C | 15M |
| 10/2020 | TigerConnect | Series D | 0 |
| 9/2017 | Alcresta | Series C | 60M |
| 4/2019 | Bardy Diagnostics | Series B | 35.5M |
| 6/2017 | Trice Medical | Series C | 0 |
| 1/2019 | Trice Medical | Series C | 0 |
| 7/2015 | Castle Biosciences | Series F | 11.7M |
| 11/2022 | Venus Concept | Post-IPO Equity | 6.7M |
| 9/2021 | RareCyte | Series G | 0 |
| 7/2017 | Venus Concept | Venture Round | 0 |
| 10/2016 | Avizia | Series A | 6M |
| 11/2019 | Venus Concept | Private Placement | 28M |
| 3/2016 | Spirox | Series C | 45M |
| 1/2021 | EverlyWell | Series D | 75M |
| 7/2016 | Magnolia Medical Technologies | Series B | 13.8M |
| 1/2015 | Trice Medical | Series B | 6.5M |
| 5/2020 | Pulmonx | Equity | 66M |
| 1/2023 | Perspectum | Series C | 37.4M |
| 7/2018 | Ajax Health | Series B | 120M |
| 4/2017 | Avedro | Venture Round | 0 |
| 4/2020 | Perspectum | Series B | 35.9M |
| 1/2018 | Springbuk | Series B | 20M |
| 6/2022 | Nomad Health | Venture Round | 0 |
| 2/2022 | Magnolia Medical Technologies | Venture Round | 0 |
| 11/2021 | Lunit | Venture Round | 0 |
| 9/2021 | RareCyte | Series G | 0 |
| 6/2021 | Thirty Madison | Series C | 0 |
| 1/2021 | EverlyWell | Secondary Market | 0 |
| 10/2020 | TigerConnect | Series D | 0 |
| 5/2020 | Pulmonx | Series H | 0 |
| 4/2020 | Perspectum | Series B | 0 |
| 12/2019 | RareCyte | Series F | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
